This content is from: Premium

RA Capital’s Covid Play

The life sciences firm is gearing up for two more IPOs this week, including one for a company that is developing a treatment for Covid-19.

RA Capital is on a harvesting spree.The life sciences specialist is gearing up for initial public offerings of two of its private investments for the second straight week, including the IPO of a company that is currently developing a treatment for Covid-19.In the past month or so around ten of

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content